Limitless X terminates four license agreements with key licensors effective Oct 1, 2023

Limitless X Holdings Inc.

Entered four Termination Agreements with Limitless Performance, Amarose, Divatrim, and SMILZ, Inc. on Nov 1, 2023.
All rights, licenses, and privileges under the License Agreements ceased as of Oct 1, 2023.
Company may sell remaining finished product inventory of licensors' products through Nov 30, 2023.
Amounts due through termination date remain; surviving provisions (confidentiality, non-compete) continue.
Company retained its license for the NZT-48 brand.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.95

Limitless X Holdings Inc. terminated Manufacturing and Distributorship License Agreements with Limitless Performance, Inc., Amarose, Inc., Divatrim, Inc., and SMILZ, Inc. valued at All rights, licenses, and privileges ceased and terminated as of October 1, 2023; company may sell r (effective 2023-10-01).

Action: termination
Agreement: license
Counterparty: Limitless Performance, Inc., Amarose, Inc., Divatrim, Inc., and SMILZ, Inc.
Value: All rights, licenses, and privileges ceased and terminated as of October 1, 2023; company may sell r
Effective: 2023-10-01

Exact text from the filing

On November 1, 2023, Limitless X Holdings, Inc. (the “Company”) entered into four Termination Agreements (collectively, the “Termination Agreements”) for the four Manufacturing and Distributorship License Agreements (collectively, the “License Agreements”) with each of Limitless Performance, Inc., Amarose, Inc., Divatrim, Inc., and SMILZ, Inc. (collectively, the “Licensors”).

View on SEC.gov

Browse all material agreements →

Limitless X Holdings Inc. filing history →

Source: SEC EDGAR

accession 0001493152-23-039493

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.